Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar

Mass drug administration has received growing interest to accelerate the elimination of multi-drug resistant malaria in the Greater Mekong Subregion. Targeted MDA, sometimes referred to as focal MDA, is the practice of delivering MDA to high incidence subpopulations only, rather than the entire population. Policymakers and funders need to know what resources are required if MDA, targeted or otherwise, is to be included in elimination packages beyond existing malaria interventions.

Three activities (community engagement, identification of villages for targeted MDA, and conducting mass treatment in target villages) were evaluated. A costing tool was developed to aid future analyses.

Drug-based Strategies
Financing & Economics
Modeling

May 2014 — Dec 2019

Myanmar

Mass Drug Administration (MDA)